InvestSMART

ReNerve Limited (ASX: RNV) - Announcements

- Current share price for RNV : $0.077

ASX company news and announcements for ReNerve Limited (RNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ReNerve Limited (RNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ReNerve Limited (RNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ReNerve Limited (RNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 ReNerve announces Board changes 4 Dec 2025 8:33AM $0.100 $0.077 fallen by 23%
$11 Correction to Notice of General Meeting/Proxy Form 3 Dec 2025 8:28AM $0.105 $0.077 fallen by 26.67%
$11 Change of Director's Interest Notice - D Rhodes 2 Dec 2025 8:28AM $0.105 $0.077 fallen by 26.67%
$11 Change of Director's Interest Notice - J Chick 2 Dec 2025 8:28AM $0.105 $0.077 fallen by 26.67%
$11 Notice of General Meeting/Proxy Form 2 Dec 2025 8:28AM $0.105 $0.077 fallen by 26.67%
$11 Notification regarding unquoted securities - RNV 2 Dec 2025 8:28AM $0.105 $0.077 fallen by 26.67%
$11 Cleansing Notice 1 Dec 2025 8:34AM $0.115 $0.077 fallen by 33.04%
$11 Application for quotation of securities - RNV 28 Nov 2025 8:22AM $0.110 $0.077 fallen by 30%
$11 Results of Meeting 27 Nov 2025 10:54AM $0.110 $0.077 fallen by 30%
$11 ReNerve announces Board Renewal Process 27 Nov 2025 10:52AM $0.110 $0.077 fallen by 30%
$11 ReNerve AGM Presentation 27 Nov 2025 9:36AM $0.115 $0.077 fallen by 33.04%
$11 Proposed issue of securities - RNV 20 Nov 2025 9:46AM $0.155 $0.077 fallen by 50.32%
$11 Proposed issue of securities - RNV 20 Nov 2025 9:46AM $0.155 $0.077 fallen by 50.32%
$11 ReNerve completes $3.2m capital raising 20 Nov 2025 9:46AM $0.155 $0.077 fallen by 50.32%
$11 Trading Halt 18 Nov 2025 9:06AM $0.155 $0.077 fallen by 50.32%
$11 Nerve Cuff approved for use in US DoD and VA hospitals 13 Nov 2025 9:32AM $0.105 $0.077 fallen by 26.67%
$11 Quarterly Investor Presentation 10 Nov 2025 10:36AM $0.098 $0.077 fallen by 21.43%
$11 ReNerve Clinical Study Expansion 5 Nov 2025 9:42AM $0.096 $0.077 fallen by 19.79%
$11 Quarterly Investor Webinar 5 Nov 2025 9:39AM $0.096 $0.077 fallen by 19.79%
$11 Notice of Annual General Meeting/Proxy Form 29 Oct 2025 10:00AM $0.105 $0.077 fallen by 26.67%
$11 Notification regarding unquoted securities - RNV 24 Oct 2025 10:23AM $0.115 $0.077 fallen by 33.04%
$11 Q1 FY26 Activities Report and Appendix 4C 23 Oct 2025 8:46AM $0.130 $0.077 fallen by 40.77%
$11 ReNerve achieves first sales of amniotic tissue range 14 Oct 2025 9:06AM $0.123 $0.077 fallen by 37.14%
$11 ReNerve products feature in industry forum at ASSH 10 Oct 2025 9:28AM $0.135 $0.077 fallen by 42.96%
$11 Investor Roadshow Presentation 29 Sep 2025 9:29AM $0.120 $0.077 fallen by 35.83%

51 - 75 of 153 results

Page 3 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.